Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (4)
• Isolated peripheral blood mononuclear cells (non viable) (3)
• Other (1)
• Plasma (single spun) (4)
• Saliva (3)
• Serum (6)
• Stool (2)
• Swab medium (2)
• Urine (random) (2)

Microscopic Assessment

• Affected (1)
• Not applicable (6)

Storage Temperature

• -35°C to -18°C (1)
• -85°C to -60°C (6)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (5)
• Followup records (5)
• Freezer temperature logs (2)
• Genomic datasets (2)
• Microbiological results (4)
• Participant Ethnicity (3)
• Physiological/biochemical measurements (2)
• Pre-analytical data (3)
• Quality indicators (2)
• Survey data (5)
• Treatment records (4)

Timeframe

• Immediate (2)
• 0 - 3 months (7)
• 3 - 6 months (2)
• > 6 months (3)

Participant Count

• 1 - 10 (1)
• 11 - 100 (2)
• 101 - 500 (4)
• 501 - 1000 (1)
• 1001 - 3000 (1)

Sex

• Male (1)
• Female (1)
• Both sexes (6)

Age Range

• Young adult (18 - 40 years) (7)

Biobank Services

• Ability to recontact (3)
• Cell culture (2)
• Data analytics (2)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (2)

Collection Type

• Case-control (1)
• Cohort (1)
• Cross-sectional (2)
• Disease specific (4)

Consent Restriction

• No Commercial restriction (7)
• No Disease area restriction (7)
• No Export restriction (6)
• No Genetic analysis restriction (6)
• No Human genetic analysis restriction (5)
• No restrictions (2)
• No Project specific restriction (7)
• No Scope of use restriction (4)

Collection Status

• Completed (3)
• In progress (4)
• Not-started (1)

Access Condition

• Open to applicants (4)
• Open only through collaboration (2)
• Data access only (1)

Country

• Belgium (1)
• Peru (3)
• South Africa (1)
• Switzerland (1)
• Uganda (1)
• United States (1)

County